Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

PRPO - Precipio Inc


IEX Last Trade
6.52
0.052   0.804%

Share volume: 2,856
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST

PREVIOUS CLOSE
CHG
CHG%

$6.47
0.05
0.81%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
-3.53%
1 Month
21.71%
3 Months
9.88%
6 Months
-1.59%
1 Year
-0.61%
2 Year
-72.67%
Key data
Stock price
$6.52
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$4.31 - $8.99
52 WEEK CHANGE
-$0.01
MARKET CAP 
9.723 M
YIELD 
N/A
SHARES OUTSTANDING 
1.482 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$13,527
AVERAGE 30 VOLUME 
$12,059
Company detail
CEO: Paul Kinnon
Region: US
Website: http://www.precipiodx.com/
Employees: 88
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. our goal is to assist oncologists in providing the best care for their patients. at the intersection of academia, cancer research, and diagnostics, we connect physicians with world-renown pathologists at the yale school of medicine. at precipio, our customers and their patients benefit from the most accurate, expert diagnosis. we provide our customers exclusive access to some of the most innovative tests in the field of molecular diagnostics, developed through cutting edge research, and the ongoing pursuit and refinement of the science of personalized medicine.

Recent news